Lewis Karen
Insider CIK 1814304 · APLS Chief People Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-29 | 2025-01-30 | 364 | $29.52 | $10.7K | 70,251 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-22 | 2025-01-23 | 1,751 | $30.43 | $53.3K | 70,615 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2025-01-21 | 2025-01-21 | 28,508 | — | $0 | 72,366 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-17 | 2025-01-21 | 1,241 | $29.96 | $37.2K | 43,858 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-13 | 2025-01-14 | 1,599 | $28.70 | $45.9K | 45,099 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-30 | 2024-01-31 | 883 | $65.53 | $57.9K | 46,387 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-29 | 2024-01-31 | 367 | $64.14 | $23.5K | 47,270 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-23 | 2024-01-24 | 4,286 | $63.69 | $273.0K | 47,637 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-22 | 2024-01-23 | 1,738 | $65.00 | $113.0K | 51,923 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-17 | 2024-01-18 | 3,276 | $65.58 | $214.8K | 53,661 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2024-01-16 | 2024-01-17 | 24,666 | $66.30 | $1.64M | 24,666 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-16 | 2024-01-17 | 1,632 | $66.81 | $109.0K | 56,937 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2024-01-16 | 2024-01-17 | 16,963 | — | $0 | 58,569 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-06-01 | 2023-06-02 | 5,000 | — | $0 | 106,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-06-01 | 2023-06-02 | 5,000 | $86.00 | $430.0K | 41,504 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-06-01 | 2023-06-02 | 5,000 | $34.11 | $170.6K | 46,504 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-04-03 | 2023-04-05 | 5,000 | — | $0 | 111,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-04-03 | 2023-04-05 | 5,000 | $75.00 | $375.0K | 41,430 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-04-03 | 2023-04-05 | 5,000 | $34.11 | $170.6K | 46,430 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-02-23 | 2023-02-27 | 1,104 | $68.76 | $75.9K | 41,430 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-02-21 | 2023-02-22 | 9,402 | — | $0 | 9,402 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-02-21 | 2023-02-22 | 6,628 | — | $0 | 43,087 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-02-21 | 2023-02-22 | 553 | $58.50 | $32.4K | 42,534 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-01-30 | 2023-01-31 | 883 | $52.76 | $46.6K | 36,459 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-01-27 | 2023-01-30 | 367 | $52.77 | $19.4K | 37,342 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-01-23 | 2023-01-25 | 2,955 | $51.58 | $152.4K | 37,709 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-01-20 | 2023-01-24 | 1,411 | $52.05 | $73.4K | 40,664 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-01-12 | 2023-01-17 | 30,845 | $52.66 | $1.62M | 30,845 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-01-12 | 2023-01-17 | 19,634 | — | $0 | 42,075 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other deriv | 2022-04-25 | 2023-01-17 | 7,500 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other | 2022-04-25 | 2023-01-17 | 1,250 | — | $0 | 22,224 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-01-28 | 2022-02-01 | 434 | $38.59 | $16.7K | 23,474 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2022-01-21 | 2022-01-25 | 24,774 | — | $0 | 24,774 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2022-01-21 | 2022-01-25 | 17,466 | — | $0 | 23,908 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 1,250 | — | $0 | 6,250 | SEC↗ |